Updates

Congressional Briefing Panelist Bios

Apr 2, 2015

Keynote Speaker Peter Bach, MD, MAPP Director The system wide impact of new… Read More

New Drug Report Confirms Drug Prices On Unsustainable Path

Mar 11, 2015

Reaction from National Coalition on Health Care President and CEO John Rother… Read More

Speaking Engagements Broaden Discussion on Unsustainable Drug Prices

Feb 24, 2015

John Rother to Make Appearances at AMA National Advocacy Conference and National Conference of Insurance Legislators. Read More

CVS girds for battle over cholesterol drugs

Feb 17, 2015

Drug retail giant CVS Health Corp. is girding to do battle with pharmaceutical companies over a coming class of cholesterol drugs that CVS says could cost the nation’s health-care system $150 billion a year. Read More

On health-care prices, Obama goes where Obamacare doesn’t

Feb 9, 2015

Ever since Obamacare took effect, Republicans have warned of mission creep: that a law bringing more government regulation to health care would eventually morph into single-payer. Read More

American College of Physicians Joins Campaign for Sustainable Rx Pricing

Feb 3, 2015

The American College of Physicians, the largest medical-specialty organization and second-largest physician group in the United States, has joined the Campaign for Sustainable Rx Pricing (CSRxP), a broad-based coalition working for solutions to skyrocketing prescription medicine prices. Read More

Doctors group joins fight against ‘skyrocketing’ drug prices

Feb 3, 2015

A national group of more than 140,000 physicians on Tuesday joined a coalition dedicated to reversing the growing trend of high-cost specialty drugs, which are being blamed for straining the finances of patients, insurance plans and public health coverage programs. Read More

Insurers eye pharma discounts beyond hepatitis C

Feb 2, 2015

The pricing battle pitting insurers and pharmacy benefit managers against drugmakers over a new breed of high-priced and highly effective treatments for hepatitis C may be a preview of tougher negotiations for coverage of other blockbuster drugs. Read More

Obama Health Budget Calls for Authority to Negotiate Drug Prices

Feb 2, 2015

The Obama administration’s fiscal 2016 budget request calls for allowing the government to negotiate the price of prescription drugs and giving regulators new funding to fight Ebola. Read More

Gilead Sciences Earnings: What to Watch

Feb 2, 2015

Gilead Sciences Inc. is scheduled to announce its fourth-quarter earnings Feb. 3. Last year, Gilead’s Sovaldi had the top-selling drug launch in history with more than $8.5 billion in sales through the end of September. Read More

Obama’s Budget Targets High Cost of Cutting-Edge Drugs

Feb 2, 2015

With patients facing more exposure to the cost of revolutionary new medications, the budget President Barack Obama released Monday reopened a debate on whether government should use its buying power to squeeze the pharmaceutical industry for lower prices. Read More

White House bemoans ‘rapidly growing’ drug prices

Feb 2, 2015

The White House said Monday that it is "deeply concerned with the rapidly growing prices of specialty and brand name drugs," a victory for critics of pharmaceutical companies. Read More